The "Family Vaccine Protection Act" aims to formally establish the Advisory Committee on Immunization Practices (ACIP) within the Public Health Service Act, ensuring its continued operation and defining its responsibilities. This codification mandates that ACIP provide advice, guidance, and recommendations to the Director of the Centers for Disease Control and Prevention (CDC) regarding the use of vaccines, strictly based on a preponderance of the best available, peer-reviewed scientific evidence . A key provision requires the CDC Director to adopt ACIP's recommendations unless they are determined not to be supported by the scientific evidence. In such cases, the Director must publish the basis for not adopting the recommendation and notify relevant congressional committees within 48 hours, ensuring transparency and accountability. ACIP is also tasked with promptly considering new vaccines or indications, making recommendations within 90 days of notification from license holders, and providing guidance for vaccines authorized for emergency use . The bill outlines ACIP's specific duties, including making immunization recommendations for purposes of health insurance coverage under the Public Health Service Act and establishing the list of vaccines for the Vaccines for Children Program . Recommendations must detail population groups, contraindications, and recognized adverse events. The committee will report to the CDC Director and hold public meetings at least three times annually, and within 90 days of a new vaccine's first marketing. Membership of ACIP will consist of 15 to 19 individuals with diverse expertise, such as epidemiology, immunology, vaccine safety, and consumer perspectives, appointed by the Secretary based on recommendations from the Comptroller General. The bill also includes six non-voting ex-officio members from various federal health agencies. Furthermore, the legislation authorizes $2.8 million annually for fiscal years 2026 through 2029 to support ACIP's operations. Finally, the bill amends the Public Health Service Act concerning the National Vaccine Injury Compensation Program . It stipulates that any removal or modification of a vaccine from the Vaccine Injury Table must be supported by a preponderance of the best available scientific evidence regarding the vaccine's safety or efficacy, reinforcing the scientific integrity of compensation decisions.